[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@futurelifefirst](/creator/twitter/futurelifefirst)
"@thegarybrecka Surfing 🏄"  
[X Link](https://x.com/futurelifefirst/status/1979666086930067704) [@futurelifefirst](/creator/x/futurelifefirst) 2025-10-18T21:49Z XX followers, XX engagements


"Bitesize biotech of the week 🧬 X. Rapt Therapeutics breaks away in chronic hives market Their experimental treatment RPT904 out-performed a standard therapy (Xolair) in a head-to-head trial for chronic spontaneous urticariashowing higher hive-free rates and longer dosing intervals"  
[X Link](https://x.com/futurelifefirst/status/1980274299433828532) [@futurelifefirst](/creator/x/futurelifefirst) 2025-10-20T14:05Z XX followers, XX engagements


"2. Nabla Bio & Takeda Pharmaceutical deepen AI-driven drug design tie-up The partnership expands Nablas AI platform JAM to rapidly generate biologics for hard targets; upfront payment in the tens of millions plus potential $1-billion in milestones"  
[X Link](https://x.com/futurelifefirst/status/1980274301379965320) [@futurelifefirst](/creator/x/futurelifefirst) 2025-10-20T14:05Z XX followers, XX engagements